[go: up one dir, main page]

AU2002224905A1 - Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes - Google Patents

Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes

Info

Publication number
AU2002224905A1
AU2002224905A1 AU2002224905A AU2490502A AU2002224905A1 AU 2002224905 A1 AU2002224905 A1 AU 2002224905A1 AU 2002224905 A AU2002224905 A AU 2002224905A AU 2490502 A AU2490502 A AU 2490502A AU 2002224905 A1 AU2002224905 A1 AU 2002224905A1
Authority
AU
Australia
Prior art keywords
bromelain
treatment
wound healing
inflammatory diseases
adjuvant therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224905A
Inventor
Klaus Eschmann
Rainer Maurer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ursapharm Arzneimittel GmbH
Original Assignee
URSAPHARM ARZNEIMITTEL GmbH AN
Ursapharm Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by URSAPHARM ARZNEIMITTEL GmbH AN, Ursapharm Arzneimittel GmbH filed Critical URSAPHARM ARZNEIMITTEL GmbH AN
Publication of AU2002224905A1 publication Critical patent/AU2002224905A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002224905A 2000-11-28 2001-11-28 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes Abandoned AU2002224905A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00125986 2000-11-28
EP00125986.0A EP1208849B1 (en) 2000-11-28 2000-11-28 Use of bromelain for adjuvant therapy during wound healing process
PCT/EP2001/013897 WO2002043755A1 (en) 2000-11-28 2001-11-28 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes

Publications (1)

Publication Number Publication Date
AU2002224905A1 true AU2002224905A1 (en) 2002-06-11

Family

ID=8170509

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224905A Abandoned AU2002224905A1 (en) 2000-11-28 2001-11-28 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes

Country Status (9)

Country Link
US (1) US7731958B2 (en)
EP (2) EP1208849B1 (en)
JP (1) JP4330878B2 (en)
KR (1) KR100856965B1 (en)
CN (1) CN100469390C (en)
AU (1) AU2002224905A1 (en)
BR (1) BR0115610A (en)
CA (1) CA2424483C (en)
WO (1) WO2002043755A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006104080A (en) * 2004-10-01 2006-04-20 Cross:Kk Composition and health food having prophylactic or therapeutic effect on gout and bloodstream disorder caused by uric acid
IT202100015704A1 (en) * 2021-06-16 2022-12-16 Neilos S R L "Composition for the prevention and/or treatment of inflammatory conditions"

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3224942A (en) * 1962-01-15 1965-12-21 Rorer Inc William H Anti-inflammatory, anti-edema and anti-thrombi drug
EP0421021A1 (en) * 1989-10-06 1991-04-10 MUCOS EMULSIONSGESELLSCHAFT m.b.H. Use of catabolic enzymes to activate macrophages and/or NK cells, medicinal composition containing these enzymes for the activation of macrophages and/or NK cells
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
US5560910A (en) * 1994-08-26 1996-10-01 Crandall; Wilson T. Topical anti-inflammatory composition and method
JP4673454B2 (en) * 1997-02-25 2011-04-20 サランティス プロプライエタリィ リミテッド Bromelain ingredients
EP1012305A1 (en) * 1997-02-25 2000-06-28 Cortecs (UK) Limited Component of bromelain

Also Published As

Publication number Publication date
EP1337268A1 (en) 2003-08-27
EP1208849A1 (en) 2002-05-29
JP4330878B2 (en) 2009-09-16
BR0115610A (en) 2003-09-16
CN100469390C (en) 2009-03-18
JP2004519433A (en) 2004-07-02
CA2424483C (en) 2011-06-07
US7731958B2 (en) 2010-06-08
CA2424483A1 (en) 2002-06-06
EP1208849B1 (en) 2015-10-28
KR20030064794A (en) 2003-08-02
CN1476334A (en) 2004-02-18
KR100856965B1 (en) 2008-09-04
US20040043018A1 (en) 2004-03-04
WO2002043755A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
EP1404343A4 (en) Therapeutic combinations for the treatment of hormone deficiencies
AU2002305400A1 (en) Medical device and methods of use for glaucoma treatment
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
HUP0301815A3 (en) Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2002357830A1 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
HUP0400024A3 (en) Combination for treatment of neoplastic diseases
AU2001249262A1 (en) Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2001292818A1 (en) Use of transcription factors for treating inflammation and other diseases
HUP0105310A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU2002224905A1 (en) Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
GB2365443B (en) A surgical-medical dressing for the treatment of body burns and for wound healing
GB0020588D0 (en) Treatment of wounds
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases